Porda Havas International Financial Communications Group
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held 2021-02-05 11:32
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation 2021-01-27 11:21
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 2021-01-08 20:55
Ping An of China Asset Management (Hong Kong) Wins Two Prestigious Awards 2020-12-31 16:00
Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review 2020-12-14 12:15
Yincheng Life Service Controlling Shareholder Increased its Shareholding of 4,160,000 Shares 2020-12-07 20:37
Sihuan Pharmaceutical (0460) Won the Fifth "Listed Enterprises of the Year 2020" Presented by Bloomberg Businessweek/Chinese Edition 2020-12-03 10:36
The Third Edition of CIIE in China Has a Delegation of 20 Brazilian Companies 2020-11-06 12:10
Brazil's Meat Industries Invest in Protection Against the Pandemic 2020-11-02 11:34
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases 2020-10-30 10:54
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market 2020-10-27 10:42
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China 2020-10-22 10:36
Sihuan Pharmaceutical Invests in Phase I Fund of Ascendum Capital Life Technology to Expand its Strategy in Development of Innovative Drugs 2020-10-20 11:09
JHBP (CY) Holdings Limited (6998.HK) Successfully listed on the Main Board of SEHK 2020-10-07 18:05
Announcement of Memorandum of Understanding for a Business Alliance of 5G/AI Related Businesses 2020-10-05 14:30
Genor Biopharma Announces Proposed Listing on the Main Board of SEHK 2020-09-23 12:00
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities 2020-09-21 09:25
Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program 2020-09-17 20:25
Sihuan Pharmaceutical (0460.HK): Under innovation transformation, an internationalized new pattern in construction 2020-09-15 18:05
Venus Medtech Taps into Surgical Heart Valve Market by Cooperating with Haoyue Group to Develop the Business of High-end Biomaterial Medical Devices 2020-09-10 17:56
1 3 4 5 6 7 17